Aurora Cannabis Enters Partnership With UFC to Advance Marijuana Research – TheStreet.com

Aurora Cannabis Enters Partnership With UFC to Advance Marijuana Research - TheStreet.com
UFC gets in the octagon with Aurora Cannabis in multi-million dollar partnership
The Edmonton-based cannabis producer said it will work with the fight leagues athletes in clinical studies involving pain management, inflammation, injury, exercise recovery, and mental well-being.

Cannabidiol or CBD is a wellness-oriented cannabis compound increasingly being infused into everything from coffee to bath bombs.

This global partnership places focus squarely on the health and well-being of UFCs talented and highly trained athletes, Aurora CEO Terry Booth wrote in a news release on Tuesday.

The Aurora-UFC research partnership creates a global platform to launch targeted educational and awareness campaigns, while creating numerous opportunities to accelerate our global CBD business.

In addition to the Companys rapid organic growth and strong execution on strategic M&A, which to date includes 17 wholly owned subsidiary companies – MedReleaf, CanvasRX, Peloton Pharmaceutical, Aurora Deutschland, H2 Biopharma, Urban Cultivator, BC Northern Lights, Larssen Greenhouses, CanniMed Therapeutics, Anandia, HotHouse Consulting, MED Colombia, Agropro, Borela, ICC Labs, Whistler, and Chemi Pharmaceutical – Aurora is distinguished by its reputation as a partner and employer of choice in the global cannabis sector, having invested in and established strategic partnerships with a range of leading innovators, including: Radient Technologies Inc. (TSXV: RTI), Hempco Food and Fiber Inc. (TSXV: HEMP), Cann Group Ltd. (ASX: CAN), Micron Waste Technologies Inc. (CSE: MWM), Choom Holdings Inc. (CSE: CHOO), CTT Pharmaceuticals (OTCC: CTTH), Alcanna Inc. (TSX: CLIQ), High Tide Inc. (CSE: HITI), EnWave Corporation (TSXV: ENW), Capcium Inc. (private), Evio Beauty Group (private), and Wagner Dimas (private).

Auroras research will be led by Dr. Jason Dyck, a professor at the University of Alberta and a Canada Research Chair in molecular medicine. He also serves as an independent director on Auroras board.

Highly differentiated from its peers, Aurora has established a uniquely advanced, consistent and efficient production strategy, based on purpose-built facilities that integrate leading-edge technologies across all processes, defined by extensive automation and customization, resulting in the massive scale production of high-quality consistent product. Intended to be replicable and scalable globally, our production facilities are designed to produce cannabis of significant scale, with high quality, industry-leading yields, and low per gram production costs. Each of Auroras facilities is built to meet European Union Good Manufacturing Practices ("EU GMP") standards. Certification has been granted to Auroras first production facility in Mountain View County, the MedReleaf Markham facility, and its wholly owned European medical cannabis distributor Aurora Deutschland. All Aurora facilities are designed and built to the EU GMP standard.

Since the day we opened the Performance Institute, our primary goal was to offer UFC athletes the best possible training, nutrition, and recovery services, UFC President Dana White added in the release.

The research will be conducted at the UFCs Performance Institute in Las Vegas, Nevada, in collaboration with UFCs sports performance team, as well as with athletes who choose to participate in the studies. Clinical studies will focus on pain management, inflammation, injury/exercise recovery, and mental well-being. Auroras research will be led by Dr. Jason Dyck, Professor at the University of Alberta and a Canada Research Chair in Molecular Medicine. He also serves as an indendent director on the board of Aurora Cannabis, where he provides valuable oversight for the Companys scientific efforts.

This partnership with Aurora is an extension of that goal, and were looking forward to collaborating with Aurora to find new ways to improve the health and safety of athletes who compete in UFC.

EDMONTON, May 21, 2019 /PRNewswire/ – Aurora Cannabis Inc. ("Aurora" or the "Company") (NYSE: ACB) (TSX: ACB), the Canadian company defining the future of cannabis worldwide, and UFC®, the worlds premier mixed martial arts organization, are excited to announce an exclusive, multi-year, multi-million dollar, global partnership that is expected to significantly advance further clinical research on the relationship between 100% hemp derived Cannabidiol (CBD) products and athlete wellness and recovery, with a view to accelerating CBD product development and education.

The move follows Canopy Growth Corp.s (WEED.TO) partnership with the NHL Alumni Association. Canopy announced in March that it would conduct a double-blind clinical trial involving about 100 former hockey stars aimed at reducing reliance on highly-addictive opioids and other pharmaceutical painkillers.

Share Share UFC inks multi-year, multi-million dollar CBD partnership with Aurora Cannabis tweet share Reddit Pocket Flipboard Email Esther Lin Hey, remember when Nate Diaz whipped out his E-pen and started vaping at the UFC 202 press conference and USADA lost its shit?

Headquartered in Edmonton, Alberta, Canada with funded capacity in excess of 625,000 kg per annum and sales and operations in 24 countries across five continents, Aurora is one of the worlds largest and leading cannabis companies. Aurora is vertically integrated and horizontally diversified across every key segment of the value chain, from facility engineering and design to cannabis breeding and genetics research, cannabis and hemp production, derivatives, high value-add product development, home cultivation, wholesale and retail distribution.

Thats because the worlds preeminent combat sports promotion just inked a multi-year, multi-million dollar partnership with Aurora Cannabis to help lead continued research into the health benefits of cannabidiol (CBD).

This global partnership places focus squarely on the health and well-being of UFCs talented and highly trained athletes, said Aurora Chief Executive Terry Booth. The Aurora-UFC research partnership creates a global platform to launch targeted educational and awareness campaigns, while creating numerous opportunities to accelerate our global CBD business.

The research will be conducted at the promotions Performance institute in Las Vegas, focusing on pain management, inflammation, recovery and mental health. In other words, UFC has found yet another reason to lock the doors and block the stairs.


Posted in Aurora